Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology

This publication has 40 references indexed in Scilit:

• Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats
  Peptides, 1984
• Selective Alteration of Secretin-Stimulated Cardiac Adenylate Cyclase Activity in Streptozotocin-Diabetic Rats
  Hormone and Metabolic Research, 1983
• Vasoactive Intestinal Peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes
  Peptides, 1982
• Comparison of VIP-secretin receptors in rat and human lung
  Peptides, 1981
• Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1981
• Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid rats
  FEBS Letters, 1981
• The epinephrine‐induced activation of the cardiac slow Ca²⁺ channel is mediated by the cAMP‐dependent phosphorylation of calciductin, a 23 000 M_r sarcolemmal protein
  FEBS Letters, 1981
• Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI)
  FEBS Letters, 1980
• Reduced number of β-adrenergic receptors in the myocardium of spontaneously hypertensive rats
  Biochemical and Biophysical Research Communications, 1978
• EFFECT OF SECRETIN ON PACEMAKER ACTIVITY AND CONTRACTILITY IN THE ISOLATED BLOOD-PERFUSED ATRIUM OF THE DOG
  Clinical and Experimental Pharmacology and Physiology, 1976